Valion Bio, Inc. (VBIO)

NASDAQ

$3.71

$+1.11

(+39.05%)

Regular Market

Valion Bio, Inc. (VBIO) Live Price Chart

Last updated: ⁦2026-09-30 13:49:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Valion Bio, Inc. (VBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.71, with a market capitalization of $2.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.05 to $32.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.40M
Open	$4.00
Day's High	$32.50
Day's Low	$2.05
Previous Close	$2.83
Volume	41.72M
Average Volume	628.40K
P/E Ratio	--
52-Week High	$32.50
52-Week Low	$2.05
Dividend Yield	--
Earnings Date	--

Valion Bio, Inc. (VBIO) Stock Price Today

Valion Bio, Inc. (VBIO) is currently trading at $3.71 as of 2026-09-30 13:32:21, up 30.95% ($0.88) from the previous close of $2.83

During today's regular trading session, VBIO has traded between $2.05 and $32.50, with a trading volume of 41.72M shares. The current price is near the lower end of today's range.

Valion Bio, Inc. (VBIO) 7-Day Stock Price Change

Over the past seven days, Valion Bio, Inc. (VBIO) moved from $2.38 to $3.71, representing a gain of 55.71% ($1.33).

The stock traded between $2.13 and $4.32 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.13 million shares, up versus the previous seven-day period, indicating higher trading activity.

VBIO 52-Week Price Position

Position in Range: 5.4%

52W Low$2.05

52W High$32.50

VBIO is currently trading at $3.71, placing it 5.4% of the way from its 52-week low of $2.05 to its 52-week high of $32.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Valion Bio, Inc. (VBIO)?

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Valion Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	52
Exchange	NASDAQ
Company Website	https://www.tivichealth.com

How to Buy Valion Bio, Inc. (VBIO) Stock on MEXC

Eligible investors can buy real shares of Valion Bio, Inc. (VBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VBIO and Place Your Order

Open the RealStocks trading page and search for VBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Valion Bio, Inc. (VBIO) stock price today?

Valion Bio, Inc. (VBIO) is currently trading at $ 3.71, up 30.95% ($0.88) from the previous close of $ 2.83. Intraday prices update in real time during regular trading hours.

2.Is VBIO stock going up or down today?

As of 2026-09-30 13:32:21, VBIO is trading at $ 3.71, up 30.95% ($0.88) from its previous close of $ 2.83. The stock has traded between $ 2.05 and $ 32.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is VBIO pre-market price?

As of 2026-09-30 13:32:21, VBIO is trading at $ 3.92 in pre-market trading, up 38.37% ($1.09) from the previous close of $ 2.83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VBIO after-hours price?

As of 2026-09-30 13:32:21, VBIO is trading at $ 2.76 in after-hours trading, down 2.37% ($0.07) from the regular-session close of $ 2.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VBIO stock trading now?

VBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VBIO sit relative to its 52-week high and low?

Over the past 52 weeks, VBIO has traded between a low of $ 2.05 and a high of $ 32.50. At $ 3.71, the stock is positioned 5.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Valion Bio, Inc. in?

Valion Bio, Inc. (VBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Valion Bio, Inc.'s market capitalization and where is it listed?

Valion Bio, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.40M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VBIO valued in terms of P/E ratio and EPS?

VBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -18.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Valion Bio, Inc. pay a dividend?

Valion Bio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.